EGFR and non-small cell lung carcinoma: Because the NCDB is a clinical database sourced from registry data, other potential confounders, such as EGFR, ALK, ROS mutational status, which are known predictive biomarkers for NSCLC, and differ by sex, were missing in the NCDB.